Lenalidomide versus bortezomib maintenance after frontline autologous stem cell transplantation for multiple myeloma
Blood Cancer Journal, Published online: 07 January 2021; doi:10.1038/s41408-020-00390-3Lenalidomide versus bortezomib maintenance after frontline autologous stem cell transplantation for multiple myeloma
Source: Blood Cancer Journal - Category: Hematology Authors: Marc-Andrea Baertsch Elias K. Mai Thomas Hielscher Uta Bertsch Hans J. Salwender Markus Munder Stephan Fuhrmann Ulrich D ührsen Peter Brossart Kai Neben Jana Schlenzka Christina Kunz Marc S. Raab Jens Hillenga ß Anna Jauch Anja Seckinger Dirk Hose Steff Source Type: research
More News: Cancer | Cancer & Oncology | Hematology | Myeloma | Revlimid | Stem Cell Therapy | Stem Cells | Transplants | Velcade